Ethanol Boosting Systems & MIT v. Ford Motor Co. — Federal Circuit Affirms Unpatentability
Ethanol Boosting Systems LLC and MIT challenged Ford Motor Co. over US10781760B2, a patent covering optimized fuel management for direct injection ethanol enhancement of gasoline engines. The Federal Circuit affirmed the patent’s unpatentability after 699 days, extinguishing enforcement rights against Ford.
MIT and EBS lose Federal Circuit bid to salvage ethanol injection patent
Filed in January 2024, Case No. 24-1382 saw Ethanol Boosting Systems LLC (EBS) and the Massachusetts Institute of Technology jointly appeal a Patent Trial and Appeal Board determination that US10781760B2 was unpatentable. The patent, filed under application number US16/831044, covers an optimized fuel management system enabling direct injection of ethanol as an enhancement mechanism for gasoline engines — a technology with relevance to high-efficiency internal combustion engine design and emissions reduction strategies.
The Federal Circuit issued its affirmance on 23 December 2025, finding the parties’ remaining arguments unpersuasive and upholding the PTAB’s unpatentability finding in full. The basis of termination is recorded as ‘Unpatentable,’ meaning the challenged claims were cancelled and the patent no longer carries enforceable rights. For Ford Motor Co., the ruling eliminates any lingering infringement exposure on this patent. For EBS and MIT, it forecloses further appellate recourse at the Federal Circuit level on this record.
The 699-day duration from filing to decision is consistent with contested inter partes proceedings that generate a full appellate briefing cycle. The joint plaintiff structure — pairing a university technology licensor (MIT) with a commercialisation entity (EBS) — suggests the patent originated from MIT research and was licensed to EBS for enforcement, a model that commonly underpins university-derived automotive and energy technology patents. The public record does not disclose whether related patents in the same family remain active or whether parallel proceedings were filed in other venues.
Filing to Unpatentable in 699 days
699 days — longer than the median Federal Circuit patent appeal (~500 days)
Federal Circuit affirms: what the unpatentability ruling means for both parties
Affirmance means the PTAB ruling stands without reversible error
When the Federal Circuit affirms, it concludes that the tribunal below — here the PTAB — committed no reversible legal or factual error. The court considered all remaining arguments advanced by EBS and MIT and found them unpersuasive. The underlying unpatentability finding is now final at this appellate level; the challenged claims of US10781760B2 are cancelled and carry no legal force.
No reversible error foundEBS and MIT lose enforceability — patent rights extinguished
With the PTAB’s unpatentability determination affirmed, EBS and MIT can no longer assert US10781760B2 against Ford or any other party. The patent’s claims are cancelled, ending any licensing leverage the co-plaintiffs held in this technology area. Further challenge at this level would require a petition for certiorari to the Supreme Court, which is granted only in rare circumstances and does not stay the Federal Circuit’s mandate.
Enforcement rights lostFord secures freedom to operate on direct ethanol injection technology
Ford Motor Co. prevails entirely. With US10781760B2 cancelled, Ford faces no residual infringement exposure from this patent on its ethanol fuel management systems. The affirmance also strengthens Ford’s defensive posture: the PTAB’s prior art analysis, now judicially confirmed, can inform Ford’s freedom-to-operate position on related ethanol direct injection technologies going forward.
Full defendant victoryEthanol direct injection space opens as key MIT-licensed patent falls
The cancellation of US10781760B2 removes a significant IP barrier in the optimised ethanol direct injection segment of high-efficiency internal combustion engine design. OEMs, Tier 1 suppliers, and clean-fuel technology developers working in this space should assess whether related patents in the EBS/MIT family remain live, as the unpatentability finding here does not automatically affect sibling applications. The ruling may also signal prior art density in this sub-field that weakens future prosecution strategies.
IP barrier removedFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Ethanol Boosting Systems, LLC | Company | Clean-fuel technology licensing entity and MIT — co-holders of US10781760B2Search in Eureka ↗ |
| Co-Plaintiff | Massachusetts Institute of Technology | Individual | Search in Eureka ↗ |
| Defendant | Ford Motor Co. | Company | Ford Motor Co. — global automotive OEM defending against ethanol fuel injection patent claimsSearch in Eureka ↗ |
| Plaintiff counsel | Lawrence Perley Cogswell | Attorney | Counsel for Ethanol Boosting Systems, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Lantheus Medical Imaging, Inc. | Law Firm | Representing Ethanol Boosting Systems, LLCSearch in Eureka ↗ |
| Defendant counsel | Christopher Timothy Lawn Douglas | Attorney | Counsel for Ford Motor Co.Search in Eureka ↗ |
| Defendant law firm | Alston & Bird, LLP | Law Firm | Representing Ford Motor Co.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
Official order — verbatim text
The Federal Circuit’s verdict is unambiguous: all remaining arguments were considered and found unpersuasive, and the affirmance is unconditional. The court applied its standard appellate review framework — legal questions de novo, factual findings for substantial evidence — and found no basis to disturb the PTAB’s unpatentability determination. The absence of any remand instruction or partial reversal means the cancellation of US10781760B2 is complete and immediately operative.
US10781760B2 — Direct Injection Ethanol Enhancement Fuel Management System
US10781760B2, filed under application number US16/831044, protects an optimized fuel management system that enables direct injection of ethanol as a performance and efficiency enhancement mechanism for conventional gasoline engines. The technology addresses the thermodynamic and knock-resistance advantages of ethanol when delivered via direct injection — a distinct and more technically complex route than port injection — making it relevant to both high-performance and fuel-economy-optimised powertrain architectures. The patent’s MIT origins suggest it emerged from academic research into alternative fuel combustion strategies.
In the automotive sector, ethanol direct injection represents a technically credible pathway for OEMs to improve thermal efficiency and reduce CO2 emissions without full electrification. A valid, enforceable patent in this space would create material licensing exposure for any manufacturer commercialising similar fuel management architectures. The Federal Circuit’s affirmance of unpatentability removes US10781760B2 as an enforcement vector, but the underlying technology concept remains commercially active — making patent family monitoring and prior art awareness critical for engineers and IP teams working on flex-fuel or ethanol-blend powertrain systems.
Should you run an FTO analysis in light of US10781760B2?
US10781760B2 itself is now cancelled and cannot be asserted. However, R&D teams and product managers developing direct injection ethanol enhancement systems, flex-fuel management software, or high-efficiency gasoline-ethanol powertrain architectures should not treat this case as full clearance. The MIT/EBS portfolio may include continuation or divisional applications covering overlapping subject matter. Any team commercialising direct ethanol injection fuel management technology should commission a current FTO study scoped to the full US16/831044 patent family before launch.
PatSnap Eureka’s FTO Search Agent enables R&D and IP teams to map the complete patent family surrounding US16/831044, identify live sibling applications, surface the prior art cited in the PTAB proceedings, and benchmark claim scope against your specific product architecture. Eureka’s AI-assisted claim analysis can flag residual risk from related filings and generate a landscape view of competing ethanol direct injection patents — giving you the intelligence to design around live claims and accelerate clearance decisions.
Run a freedom-to-operate analysis on US10781760B2 to assess your product’s exposure
Run FTO in Eureka →Similar Federal Circuit appeals: ethanol, fuel injection and automotive patent validity
Explore Federal Circuit decisions involving automotive fuel system patents, university-backed IP enforcement, and PTAB unpatentability affirmances in the alternative fuel and engine technology sector.
What this case signals for the alternative fuel engine IP landscape
The Federal Circuit’s affirmance confirms prior art risk for ethanol direct injection patents and raises the bar for university-backed enforcement plays.
PTAB remains a powerful tool against university-licensed automotive patents
Ford’s successful inter partes challenge to a co-held MIT/EBS patent demonstrates that even university-pedigree patents with strong institutional backing are vulnerable to PTAB scrutiny. Automotive OEMs facing enforcement from university-licensor/commercialisation-entity structures should consider IPR as a primary defence strategy rather than a last resort.
Cancelled claims create freedom-to-operate windows across the supplier chain
With US10781760B2 cancelled and the Federal Circuit’s affirmance final, the ethanol direct injection design space covered by this patent is now open. Tier 1 engine system suppliers and clean-fuel OEM partners should update their FTO analyses to reflect this outcome and assess whether competing patent families present residual risk in the same technical domain.
Ethanol v Ford — key questions answered
The Federal Circuit affirmed the PTAB’s finding that US10781760B2 was unpatentable, in Case No. 24-1382 decided on 23 December 2025. All claims were cancelled and the patent is no longer enforceable. Ford Motor Co. prevailed entirely; EBS and MIT’s remaining arguments were found unpersuasive.
US10781760B2 covers an optimized fuel management system for direct injection ethanol enhancement of gasoline engines, filed under application US16/831044. The patent was jointly held by Ethanol Boosting Systems LLC and MIT. Its cancellation removes a potential infringement claim against Ford’s ethanol fuel management technologies and clears that design space for Ford and other automotive manufacturers.
Following a Federal Circuit affirmance, the only remaining avenue is a petition for writ of certiorari to the US Supreme Court. Certiorari is discretionary and rarely granted in patent validity cases. No further appeal as of right exists. The Federal Circuit’s mandate makes the cancellation of US10781760B2 operative and final at the appellate level.
No — the unpatentability finding applies only to the specific claims of US10781760B2. Continuation, divisional, or continuation-in-part applications in the same family filed under US16/831044 are not automatically cancelled. Companies operating in the ethanol direct injection space should conduct a patent family analysis to identify any live co-pending applications that may cover similar subject matter.
MIT’s co-plaintiff status suggests US10781760B2 originated from MIT-funded research and was subsequently licensed to Ethanol Boosting Systems LLC for commercialisation and enforcement. This university-licensor/commercialisation-entity model is common in automotive and clean-energy patent litigation. The Federal Circuit’s affirmance of unpatentability is notable because it demonstrates that institutional backing and academic provenance do not insulate a patent from PTAB invalidity challenges.
PatSnap Eureka searches patents and litigation data to answer instantly.